Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

138.83
Delayed Data
As of 4:02pm ET
 -0.77 / -0.55%
Today’s Change
130.45
Today|||52-Week Range
173.00
-6.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues580.6M671.0M759.3M862.9M
 
 
 
 
 
Cost of Goods Sold165.5M158.4M162.7M170.6M
 
 
 
 
 
Depreciation And Amortization18.4M17.8M16.6M15.8M
 
 
 
 
 
 
Operating ExpensesGross Income396.7M494.8M580.0M676.6M
 
 
 
 
 
General Expenses131.8M132.9M147.2M153.2M
 
 
 
 
 
Other Operating Expenses4.4M0.000.000.00
 
 
Research And Development39.4M46.5M55.4M65.5M
 
 
 
 
 
Total Operating Expenses320.1M309.1M326.4M339.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income260.5M361.9M432.8M523.4M
 
 
 
 
 
Extraordinary Credit364.0K--0.004.2M
 
 
 
Extraordinary Charge---33.3M-2.6M--
 
 
 
Interest Expense On Debt68.9M19.3M18.3M17.8M
 
 
 
 
 
Other Expenses-740.0K5.8M8.5M44.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income260.5M335.9M443.9M581.7M
 
 
 
 
 
Income Taxes-71.2M-67.8M-82.7M-96.1M
 
 
 
 
 
Minority Interest-604.0K-664.0K-472.0K-577.0K
 
 
 
 
 
Discontinued Operations264.0K-1.2M-319.0K-787.0K
 
 
 
 
 
Net Income189.0M266.2M360.4M484.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.5M44.7M44.3M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted44.6M44.7M44.3M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS$1.06$5.96$8.14$11.31
 
 
 
 
 
EPS Diluted$4.24$5.95$8.14$11.31